1. GLOBOCAN 2018 [homepage on internet]. Lyon, France: International Agency for Research on Cancer, World Health Organization; [updated September, 2018; cited October 22, 2020]. Available from: http://gco.iarc.fr/today/onlineanalysis-multi-bars?v=2018&mode=cancer&mode_population=countries&population=900&populations=900&key=asr&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Atrue%252C%2522mort%2522%253Afalse%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D&population_group_globocan_id=. Accessed September 23, 2021.
2. NCCN Guidelinesfor treatment of cancer by site. Non-small cell lung cancer. 2020 [homepage on internet]. Pennsylvania, US: National Comprehensive Cancer Network; [updated May 21, 2020; cited October 22, 2020]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed September 23, 2021.
3. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
4. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
5. Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy